DXCM241227P74000
- 0.25
- 0.000.00%
DexCom Newsroom
Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
At US$80.57, Is DexCom, Inc. (NASDAQ:DXCM) Worth Looking At Closely?
Abbott, DexCom Settlement 'Not a Complete Surprise,' Says Wells Fargo
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $94
DexCom, Abbott Agree to Settlement in Patent Litigation
Express News | Abbott: There Are No Financial Payments Associated With Settlement From Either Abbott or Dexcom
Express News | Abbott: Agrees to Global Continuous Glucose Monitoring Litigation Settlement With Dexcom
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD) and Dexcom (DXCM)
DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Express News | Benzinga Market Summary: S&P Rises On PCE Data, Novo Nordisk Falls On Weight Loss Data, Diabetes Stocks Rise
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
Express News | Shares of Glucose Monitoring Stocks Are Trading Higher Following Weaker-than-expected Weight Loss Data From Novo Nordisk
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Oura Raises $200M With Investment From Dexcom
Oura Boosts Valuation to $5.2B in Latest Funding Round
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year